CoChat

Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion

Pørksen, Niels, Grøfte, Thorbjørn, Nyholm, Birgit, Holst, Jens Juul, Pincus, Steven M, Veldhuis, Johannes D, Schmitz, Ole, Butler, Peter C · 1998 · Diabetes
Cited by 42

The DOI matches its Crossref record.

Abstract

Glucagon-like peptide 1 (GLP-1) is a peptide hormone that is released from the gut after luminal stimulation. The hormone is a potent insulin secretagogue and is a potential novel pharmaceutical adjuvant in the treatment of NIDDM. Insulin is secreted as a series of punctuated secretory bursts superimposed on a basal insulin release. Recently, the contribution of these secretory bursts to overall insulin secretion has been evaluated, and studies using catheterization across the pancreas in a canine model and studies using deconvolution in humans have revealed that the majority of insulin is released during these secretory bursts. Moreover, the main regulation of insulin secretion is through perturbation of mass and frequency of these secretory bursts. The mode of delivery of insulin into the circulation seems important for insulin action, and it is therefore important to know the impact of a potential therapeutic insulin secretagogue on the mode of insulin secretion. To assess the effects of GLP-1 on the mass, frequency, amplitude, and overall contribution of pulsatile insulin secretion, we used a recently validated deconvolution model to examine these variables before and during infusion of GLP-1 in eight healthy men (age 28 ± 2 years; BMI 24 ± 2 kg/m2). At a constant glucose infusion (2.5 mg · kg−1 · min−1), near-steady state was reached at 75 min, and sampling was performed every minute at t = 75–115 and 145–185 min. At t = 115 min, an infusion of saline or GLP-1 (50 pmol · kg−1 · min−1) was given. The regularity of insulin secretion was measured by approximate entropy, a recently developed mathematical statistic, applied herein to assess the regularity in a hormone concentration time series. After GLP-1 infusion, there was an abrupt increase in the peripheral concentrations of serum Cpeptide (696 ± 65 vs. 1,538 ± 165 pmol/1) and insulin (49 ± 8 vs. 138 ±21 pmolA) concentrations. This increase was mainly due to an increase in the pulsatile component of insulin secretion that was achieved by a fourfold increase in secretory burst mass (28.2 ± 4.4 vs. 100.1 ± 15.8 pmol · .l−1· pulse−1; P < 0.001), and amplitude (12.7 ± 2.2 vs. 4.3 ± 7.7 pmol · l−1 · min−1; P < 0.002), whereas the secretory burst frequency was not affected by GLP-1 (11.5 ± 0.7 vs. 12.6 ± 0.6 pulses/h; P = 0.4). As a consequence, the detected contribution of pulsatile to overall insulin secretion was increased from 56 ± 4 to 77 ± 4% (P < 0.005). The orderliness of the insulin release process was not deteriorated by short-term GLP-1 infusion as assessed by approximate entropy (1.19 ± 0.04 vs. 1.18 ± 0.04; P = 0.7).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.47.1.45

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 42

Metadata

Authors
Pørksen, N., Grøfte, T., Nyholm, B., Holst, J. J., Pincus, S. M., Veldhuis, J. D., Schmitz, O., & Butler, P. C.
Venue
Diabetes
Published
1998-01-01
Volume
47
Issue
1
Pages
45-49
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2018668981
Cited by
42
References
0
FWCI
2.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion. https://app.cochat.ai/papers/10.2337/diab.47.1.45
The paper
Pørksen, N., Grøfte, T., Nyholm, B., Holst, J. J., Pincus, S. M., Veldhuis, J. D., Schmitz, O., & Butler, P. C. (1998). Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion. Diabetes. https://doi.org/10.2337/diab.47.1.45

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.